Skip to main content
Black Friday Sale - Get 40% off Vantage
Get Started
SubscribeLogin
Published • loading... • Updated

Stem Cell Therapy Restores Vision in Macular Degeneration Trial

Summary
Adult stem cell transplants restored vision in patients with advanced dry age-related macular degeneration in a first-in-human phase 1/2a clinical trial, with severely impaired patients gaining an average of 21.67 letters on eye charts after 12 months---the largest improvement reported to date for this therapy.

1 Articles

Medical XpressMedical Xpress
Center

Adult stem cells show therapeutic promise in treating vision loss from macular degeneration

In the United States, age-related macular degeneration is a leading cause of irreversible vision loss in people who are 60 and older.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Medical Xpress broke the news in on Tuesday, November 18, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Health icon

Health

Innovation icon

Innovation

Biotech icon

Biotech

Technology icon

Technology

Health Care icon

Health Care

Medical icon

Medical

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal